Yu-Chiao Chiu, PhD

University of Pittsburgh

Titles + affiliations

Assistant Professor
University of Pittsburgh


Intelligent identification of resistance mechanisms and prognostic markers in acute myeloid leukemia


Acute myeloid leukemia (AML) is a type of cancer that is very difficult to cure because of relapse, so we need better ways to treat it. Pharmacogenomics is a way to study how genes and drugs interact, which could help us find better treatments for AML. Researchers of this study have developed artificial intelligence methods that can use information about genes and drugs to predict how well a patient will respond to treatment. However, these methods need to be improved to work specifically for AML. The researchers plan to develop new computer programs that are better at predicting how well AML patients will respond to treatment. They hope this will help doctors choose the best treatment for each patient, and improve their chances of getting better.

Yu-Chiao - 300x300

Leukemia Research Foundation grant
$150K awarded in 2023

Disease focus
Acute myeloid leukemia (AML)

Research focus